Stocksigma LogoStocksigma Logo

Hindustan Bio Sciences Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh)

■ Revenue: 82.2 ■ EBITDA: 28.3 (Loss to Profit YoY | Loss to Profit QoQ) ■ EBITDA Margin (%): 34.4 ■ PAT: 31.0 (Loss to Profit YoY | Loss to Profit QoQ) ■

Hindustan Bio Sciences Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh)

Hindustan Bio Sciences Ltd · Outcome · 31 Oct 2026, 7:45 pm

Hindustan Bio Sciences Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh) ■ Revenue: 82.2 ■ EBITDA: 28.3 (Loss to Profit YoY | Loss to Profit QoQ) ■ EBITDA Margin (%): 34.4 ■ PAT: 31.0 (Loss to Profit YoY | Loss to Profit QoQ) ■ EPS (INR): 0.30 (Loss to Profit YoY | Loss to Profit QoQ)

Original exchange filing (PDF)

More announcements from Hindustan Bio Sciences Ltd

All Hindustan Bio Sciences Ltd announcements